5 min read
The Long View: The Doctor Who Keeps Choosing The Bare Cupboard
Eric Green went from a $13.1bn heart-disease exit to an ALS company built on a protein almost every patient loses. Trace's lead drug reached the clinic in June. Everything now rides on data that hasn't arrived.
